1.Wang Y, Liao X, Zhao X, et al. Using recombinant

tissue plasminogen activator to treat acute ischemic

stroke in China:analysis of the results from the Chinese

National Stroke Registry (CNSR)[J]. Stroke, 2011,

42:1658-1664.

2 Meretoja A, Strbian D, Mustanoja S, et al. Reducing inhospital

delay to 20 minutes in stroke thrombolysis[J].

Neurology, 2012, 79:306-313.

3 Meretoja A, Weir L, Ugalde M, et al. Helsinki model

cut stroke thrombolysis delays to 25 minutes in

Melbourne in only 4 months[J]. Neurology, 2013,

81:1071-1076.

4 Weber JE, Ebinger M, Rozanski M, et al. Prehospital

t h r omb olys i s i n a c ut e s t r oke: r e s u l t s of t he

PHANTOM-S pilot study[J]. Neurology, 2013, 80:163-

168.

5 Ebinger M, Winter B, Wendt M, et al. Effect of the

use of ambulance-based thrombolysis on time to

thrombolysis in acute ischemic stroke:a randomized

clinical trial[J]. JAMA, 2014, 311:1622-1631.

6 Fonarow GC, Smith EE, Saver JL, et al. Timeliness

of tissue-type plasminogen activator therapy in acute

ischemic stroke:patient characteristics, hospital factors,

and outcomes associated with door-to-needle times

within 60 minutes[J]. Circulation, 2011, 123:750-758.

7 Xian Y, Smith EE, Zhao X, et al. Strategies used by

hospitals to improve speed of tissue-type plasminogen

activator treatment in acute ischemic stroke[J]. Stroke,

2014, 45:1387-1395.

8 Hill MD, Rowley HA, Adler F, et al. Selection of acute

ischemic stroke patients for intra-arterial thrombolysis

with pro-urokinase by using ASPECTS[J]. Stroke, 2003,

34:1925-1931.

9 Demaerschalk BM, Silver B, Wong E, et al. ASPECT

scoring to estimate >1/3 middle cerebral artery territory

infarction[J]. Can J Neurol Sci, 2006, 33:200-204.

10 Kim BJ, Kim HJ, Lee DH, et al. Diffusion-weighted

image and fluid-attenuated inversion recovery image

mismatch:unclear-onset versus clear-onset stroke[J].

Stroke, 2014, 45:450-455.

11 Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation

of risk of hemorrhagic transformation in local intraarterial

thrombolysis in acute ischemic stroke by initial

SPECT[J]. Stroke, 1994, 25:298-303.

12 Bhatt A, Vora NA, Thomas AJ, et al. Lower pretreatment

cerebral blood volume increases hemorrhagic

risks after intra-arterial revascularization in acute

stroke[J]. Neurosurgery, 2008, 63:874-879.

13 Campbell BC, Christensen S, Butcher KS, et al.

Regional very low cerebral blood volume predicts

hemorrhagic transformation better than diffusionweighted

imaging volume and thresholded apparent

diffusion coefficient in acute ischemic stroke[J]. Stroke,

2010, 41:82-88.

14 Yassi N, Parsons MW, Christensen S, et al. Prediction

of poststroke hemorrhagic transformation using

computed tomography perfusion[J]. Stroke, 2013,

44:3039-3043.

15 Saver JL, Fonarow GC, Smith EE, et al. Time to

treatment with intravenous tissue plasminogen activator

and outcome from acute ischemic stroke[J]. JAMA,

2013, 309:2480-2488.

16 Fruehwald-Pallamar J, Szomolanyi P, Fakhrai N, et al.

Parallel imaging of the cervical spine at 3T:optimized

trade-off between speed and image quality[J]. AJNR

Am J Neuroradiol, 2012, 33:1867-1874.

17 Feigin VL, Forouzanfar MH, Krishnamurthi R, et

al. Global and regional burden of stroke during

1990-2010:findings from the Global Burden of Disease

Study 2010[J]. Lancet, 2014, 383:245-254.